Burlingame, CA, United States of America

Bryan K Chan

USPTO Granted Patents = 50 


 

Average Co-Inventor Count = 5.1

ph-index = 16

Forward Citations = 1,313(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2013)
  • Burlingame, CA (US) (2013 - 2014)
  • San Carlos, CA (US) (2012 - 2018)
  • San Francisco, CA (US) (2010 - 2021)
  • Foster City, CA (US) (2018 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
50 patents (USPTO):

Title: Innovations and Contributions of Bryan K. Chan in Patent Development

Introduction

Bryan K. Chan, based in Burlingame, CA, is a prolific inventor with a remarkable portfolio that includes 24 patents. His innovative research primarily revolves around compounds that address critical health issues, particularly those related to immune response enhancement.

Latest Patents

Among his latest contributions, Chan has developed spirocyclic 2,3-dihydro-7-azaindole compounds and has laid out their applications as inhibitors of HPK1 (hematopoietic kinase 1). These compounds are not only pivotal in treating HPK1-dependent disorders but also play a crucial role in enhancing immune responses. Additionally, he has authored patents detailing various methods for inhibiting HPK1, treating related disorders, boosting immune responses, and preparing these innovative compounds. Furthermore, his work on azaindole compounds highlights similar properties as inhibitors of HPK1, aimed at therapeutic uses and enhancing immunological functions.

Career Highlights

Throughout his career, Bryan K. Chan has held significant positions in notable organizations such as Genentech, Inc. and the Medical Research Council Technology. His extensive experience in these research environments has provided him the opportunity to contribute significantly to the fields of biotechnology and pharmaceutical innovation.

Collaborations

Collaboration has been a cornerstone of Chan's work. He has partnered with talented coworkers, including Zachary Kevin Sweeney and Anthony A. Estrada, who have shared in the development of groundbreaking technologies and methodologies in their respective fields. This collaborative spirit has further propelled advancements in their research endeavors and patent filings.

Conclusion

Bryan K. Chan continues to be an influential figure in the realm of patent development, particularly in innovations addressing immune response mechanisms. His extensive patent portfolio and collaborative work reflect his commitment to advancing medical science and enhancing health outcomes through targeted pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…